<DOC>
	<DOC>NCT00769119</DOC>
	<brief_summary>The purpose of this study is to investigate if treatment with AZD9668 for 28 days is effective in treating Bronchiectasis (Brx) and if so how it compares to placebo (a substance which does not have any action).</brief_summary>
	<brief_title>A Phase II , Placebo-controlled Study to Assess Efficacy of 28 Day Oral AZD9668 in Patients With Bronchiectasis</brief_title>
	<detailed_description />
	<mesh_term>Bronchiectasis</mesh_term>
	<criteria>Female of non child bearing potential Clinical diagnosis of bronchiectasis Be sputum producers, with history of chronic expectoration on most days Concomitant diagnosis of pulmonary disease other than bronchiectasis or COPD FEV1 of &lt;30% of predicted normal</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>August 2012</verification_date>
	<keyword>bronchiectasis</keyword>
	<keyword>Phase II</keyword>
</DOC>